Pharmaceutical

Filings signal: Despite Covid losses, pharma earnings are promising

Despite losing out on Covid sales as government funding drops off, pharma earnings look promising in the second half of 2023.

Aug 2, 2023 - 20:00
Filings signal: Despite Covid losses, pharma earnings are promising
Despite losing out on Covid sales as government funding drops off, pharma earnings look promising in the second half of 2023.
Read the original article

Tags:

Previous Article

Tyra gains orphan drug status from FDA for achondroplasia therapy

Next Article

UBC to bolster safety functions with Oracle’s cloud technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Early detection of pancreatic cancer could get a boost from AI that identifies people at higher risk

STAT+: Early detection of pancreatic cancer could get a...

Jan 26, 2024

Flagship Pioneering collaborates with Pfizer to develop new therapies

Flagship Pioneering collaborates with Pfizer to develop...

Jul 19, 2023

STAT+: ‘It was my call’: Stanford president defends decision not to correct key paper in misconduct investigation

STAT+: ‘It was my call’: Stanford president defends dec...

Apr 11, 2023